Jiangsu Recbio Technology Co., Ltd. logo

Jiangsu Recbio Technology Co., Ltd.

HKEX:2179.HK

Overview | Financials
Company Name Jiangsu Recbio Technology Co., Ltd.
Symbol 2179.HK
Currency HKD
Price 8.8
Market Cap 4,316,931,617
Dividend Yield 0%
52-week-range 7.39 - 13
Industry Biotechnology
Sector Healthcare
CEO Dr. Yong Liu
Website https://www.recbio.cn

An error occurred while fetching data.

About Jiangsu Recbio Technology Co., Ltd.

Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People's Republic of China. The company is developing vaccines for the treatment of cervical cancer and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in

Related Stocks

Sihuan Pharmaceutical Holdings Group Ltd. logo

Sihuan Pharmaceutical Holdings Group Ltd.

0460.HK

0.55 HKD

HUTCHMED (China) Limited logo

HUTCHMED (China) Limited

0013.HK

27.9 HKD

LifeTech Scientific Corporation logo

LifeTech Scientific Corporation

1302.HK

1.39 HKD

SSY Group Limited logo

SSY Group Limited

2005.HK

3.86 HKD

Jinxin Fertility Group Limited logo

Jinxin Fertility Group Limited

1951.HK

2.23 HKD

RemeGen Co., Ltd. logo

RemeGen Co., Ltd.

9995.HK

12.46 HKD

Akeso, Inc. logo

Akeso, Inc.

9926.HK

48.2 HKD

3SBio Inc. logo

3SBio Inc.

1530.HK

5.84 HKD

Shanghai Haohai Biological Technology Co., Ltd. logo

Shanghai Haohai Biological Technology Co., Ltd.

6826.HK

40.05 HKD

Grand Pharmaceutical Group Limited logo

Grand Pharmaceutical Group Limited

0512.HK

4.44 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD